Gavin Halbert

Director, Cancer Research UK Formulation Unit, Strathclyde Institute of Pharmacy and Biomedical Sciences

University of Strathclyde

Gavin’s role as Director of the Cancer Research UK Formulation Unit focuses on the development of investigational medicinal products, encompassing chemical, pharmaceutical, and analytical science. This role incorporates research covering pharmaceutics, biopharmaceutics, and quality assurance.

Gavin is a pharmacist, chemist, and qualified person who has progressed over 60 NCEs into clinical trials, including agents such as temozolomide, abiraterone acetate, and rucaparib. He has secured grants totalling £60 million and has contributed to over 300 publications, patents, and presentations.